Malcova
Developing MONARC — a narrow beam health imaging platform designed to replace the mammogram with pain-free, compression-free, lower-radiation, and more accurate imaging. Currently in human trials at Yale University with a patented human-like twin breast for testing.
Malcova's MONARC platform represents a fundamental rethink of breast imaging. Traditional mammograms require painful compression, deliver ionizing radiation, and miss a significant percentage of cancers — particularly in dense breast tissue. MONARC uses a narrow beam approach that eliminates compression entirely, reduces radiation exposure, and produces imaging data that AI models can analyze with greater precision.
The company has validated its core technology using a patented human-like twin breast phantom — a medically accurate surrogate that allows rigorous pre-clinical testing. Human trials are now underway at Yale University, one of the nation's leading academic medical centers, providing both clinical validation and institutional credibility.
Breast cancer is the most commonly diagnosed cancer in women worldwide, with over 300,000 new cases annually in the U.S. alone. The global mammography devices market exceeds $3 billion and is ripe for disruption. A pain-free, more accurate alternative has the potential to dramatically increase screening compliance — particularly among women who avoid mammograms due to discomfort — while improving early detection rates that are the single strongest predictor of survival.
Video Coming Soon
An explainer video for Malcova will be available shortly.
Webinar / Podcast Coming Soon
An investor webinar or podcast episode for Malcova will be posted here soon.
Company Resources
Investment Info
Interested in Malcova?
This company is part of our curated pool. Express interest to learn about commitment options.
Express Interest →Accredited investors only. No obligation.
Engineers 4 Medicine
Developing early diagnosis solutions for heart disease — one of the world's largest and most expensive health problems. The company's val…
View Profile →Insulinics
Diabetes health clinics in Florida targeting the massive chronic disease market. Better insulin resistance management creates meaningful …
View Profile →BioXcellerator
A regenerative medicine and stem cell therapy company serving patients seeking advanced treatment for orthopedic, autoimmune, neurologica…
View Profile →